
Aptevo Therapeutics Skyrockets on Game-Changing AML Drug News
Alright, folks, buckle up because we’ve got a hot one today! Aptevo Therapeutics (NASDAQ: APVO) is lighting up the stock market, and as of this writing, it’s up a jaw-dropping 181% at $7.90 per share. Why the fireworks? The company just dropped a bombshell …